In the News
Self-monitoring of blood glucose may improve control
Structured self-monitoring of blood glucose (SMBG) improves control and prompts more medication changes in patients with non-insulin-treated type 2 diabetes, a study found.
Adding gastric bypass to traditional management may help control comorbidities of diabetes
Adding gastric bypass surgery to intensive lifestyle-medical management may increase the chances of controlling comorbid risk factors in mild to moderately obese patients with type 2 diabetes, a recent study suggested.
NIH begins recruitment for long-term study of diabetes drug efficacy
Newly diagnosed diabetic patients are being recruited for a large national study to compare benefits and risks of four type 2 diabetes drug classes in combination with metformin.
MKSAP Quiz: Testing for diabetes
This month's quiz asks readers to evaluate a 48-year-old man with an elevated hemoglobin A1c.
Medicare prescribers use twice as many brand-name drugs as VA
Medicare beneficiaries with diabetes take many more brand-name drugs than similar patients treated in the Veterans Affairs (VA) system, adding as much as $1 billion per year to health care costs, a recent study found.
Bariatric surgery leads to short-term improved glycemic control and weight loss in moderately obese diabetics
Bariatric surgery in diabetic patients with a body mass index of 30 to 35 kg/m2 is associated with more short-term weight loss and better intermediate outcomes than nonsurgical treatments, but data on long-term effects are limited, a review found.
ACP issues high-value care recommendations for inpatient glucose management
Intensive insulin therapy (IIT) for inpatient glycemic control can result in more harm than benefit, ACP's Clinical Guidelines Committee recently reminded clinicians in a best practice advice paper.
An intensive lifestyle intervention increased remission from type 2 diabetes in overweight adults
In the randomized, controlled Look AHEAD trial, an intensive lifestyle intervention (ILI) was associated with partial remission of type 2 diabetes when compared with diabetes education and support (DES).
What to do about inexplicably high hemoglobin A1c
When hemoglobin A1c levels are higher than expected, given the self-monitoring blood glucose results, consider several possibilities.
First drug in new class approved
The FDA recently approved canaglifozin (Invokana) tablets to improve glycemic control in adults with type 2 diabetes, along with diet and exercise.
Spotlight on blood pressure control
Intensive blood pressure control may increase diabetic patients' risk of stroke or coronary heart disease, a group of researchers recently concluded in two separate publications.